Studies, harm-reduction data, and usage reports — summarized for humans.
The first Cochrane review of oral nicotine pouches as a quitting aid found only four tiny studies covering 284 people — and rated its confidence in the findings as 'very low'. Here's what we actually know.
Professor Kerstin Brismar of Karolinska Institutet says the surge in white snus use among young women may be driving the parallel rise in type 2 diabetes. She expects confirming research soon.
The FDA just released Wave 8 of the PATH Study, the federal government's most comprehensive look at nicotine pouch usage in America. Here's what the data covers.
A new study has found a connection between nicotine pouch use and gum recession. Dental professionals say the issue stems from prolonged contact with the gumline.